Immuno-Biological Laboratories Co., Ltd.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd. (株式会社免疫生物研究所, 4570), Pharmaceutical. A board of 7 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YLCK, filed 2026-06-26. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2022-03-31 | 0.6 | −0.3 | 1.7 | −27.78 | — | 63 |
| 2023-03-31 | 0.8 | −0.3 | 1.4 | −31.10 | — | 60 |
| 2024-03-31 | 0.8 | 0.2 | 1.6 | 20.05 | — | 57 |
| 2025-03-31 | 1.0 | 0.2 | 1.8 | 26.74 | — | 58 |
| 2026-03-31 | 1.0 | 0.3 | 2.2 | 35.33 | 6.00 | 54 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown